TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director September 3, 1976
TCL Archive Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded April 19, 1985
